Skip to main content
OpenTrials

Clinical trial condition

Human Epithelial Receptor (HER)-2 Positive Breast Cancer

Explore clinical trials studying Human Epithelial Receptor (HER)-2 Positive Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Human Epithelial Receptor (HER)-2 Positive Breast Cancer trial results

Completed

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

NCT01764022

Conditions
Breast Diseases, Breast Neoplasms, Human Epithelial Receptor (HER)-2 Positive Breast Cancer, +4 more
Locations
  • Brest Region Clinical Oncology Dispensary Brest, Belarus
  • Grodno Regional Hospital Grodno, Belarus
  • Gomel Region Clinical Oncology Dispensary Homyel, Belarus
  • Vitebsk State Medical University of Order of Peoples' Friendship Vitebsk, Belarus
View all 36 locations
View Trial Details

Related conditions